Emerging Research

New Clinical Trial for Myelofibrosis Patients with JAK2 Mutation

Promising results are being found in a new clinical trial for JAK2 mutation positive myelofibrosis patients.

Andrew Schorr, Srinivas K. Tantravahi, MBBS, MRCP

Hereditary Trends in MPNs

Does my risk for having an MPN increase if a close relative is diagnosed?

Angela Fleischman, MD, PhD, Esther Schorr

Upcoming Events

See all events

Dec 2 2020

Episode 12 of 14 in Facing MPN

Weighing Decisions & Outcomes for MPN Stem Cell Transplants

Wednesday, December 2, 2020

Time: 1:00 PM – 1:45 PM Pacific Time (US and Canada)

Weighing all of the variables that are involved in considering a stem cell transplant – pros and cons of treatment, affordability, success rate – can feel suffocating.

Topic Area: Myeloproliferative Neoplasms

Type: Online

Time: 1:00 PM – 1:45 PM Pacific Time (US and Canada)

Learn More

Latest News

MPN Experts Discuss Clinical Trials and Transplants

Jeanne Palmer, MD, Naveen Pemmaraju, MD, Phil Arner, Andrew Schorr

Andrew Schorr, Srinivas K. Tantravahi, MBBS, MRCP

Angela Fleischman, MD, PhD, Esther Schorr

Upcoming Events

Episode 12 of 14 in Facing MPN

Wednesday, December 2, 2020

Latest News

Jeanne Palmer, MD, Naveen Pemmaraju, MD, Phil Arner, Andrew Schorr

Jeanne Palmer, MD, Naveen Pemmaraju, MD, Andrew Schorr

Jason Gotlib, MD, MS, Andrew Schorr

Srdan Verstovsek, MD, PhD, Andrew Schorr

Jason Gotlib, MD, MS, Andrew Schorr

Guillermo Garcia-Manero, MD, Andrew Schorr

Jason Gotlib, MD, MS, Srdan Verstovsek, MD, PhD, Andrew Schorr

Naval G. Daver, MD, Andrew Schorr

Brandon McMahon, MD, Andrew Schorr

Angela Fleischman, MD, PhD, John Crispino, PhD, MBA, Andrew Schorr

Srdan Verstovsek, MD, PhD, Esther Schorr

Cancer News Sent to You

Get e-Newsletters with the most current information about your health condition sent to your email!

Cancer Types